Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30314830.
- Also identified by DOI 10.1016/j.pec.2018.10.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the effect of including an online decision aid (DA) during prostate cancer treatment counseling on decisional regret and information satisfaction in a one-year follow-up. Within a cluster RCT, 18 Dutch hospitals were randomized to DA counseling or care-as-usual, patients (n = 382) initially completed questionnaires directly after treatment decision making. Six and twelve months later regret (Decisional Regret Scale) and information satisfaction (SCIP-B) were assessed. Anxious and depressive symptoms (HADS) was included as possible covariate. After 12 months, 43 participants (15%) regretted their treatment choice and 105 participants (36%) were dissatisfied with the information that was received at the time of decision-making, regardless of being exposed to the DA. Anxious and depressive symptoms at follow-up were associated with regret and information dissatisfaction. No long-term benefical effects emerged from DA usage compared to patients who underwent standard counseling. During PCa treatment counseling, healthcare providers should be aware of anxious and depressive symptoms.
Medical subject headings
- Decision Making
- Decision Support Techniques
- Emotions
- Patient Participation
- Patient Satisfaction
- Personal Satisfaction
- Prostatic Neoplasms